KAT-002

N/A

Report date: 2024/12/16 10:25:36

NME

Base Information

Drug NameKAT-002

Drug Alias NameKAT-002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNewG Lab Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsUrinary Bladder Neoplasms

Inactive IndicationsN/A

ATC CodeN/A